Supply Chain Study Findings To have your event featured here, contact Global trials call for increased speed and accuracy in the supply chain.By Ann Neuer May 12, 2008 | The logistics of performing complex clinical trials beckons companies to...
The Eyesi Ophthalmic Surgical Simulator Ophthalmologists have a new training mantra.See one.
Simulate one.
Do one.
Teach one.
In recent years, the medical community has benefited from technological advances that simulate surgical environments.
Ophthalmologists now...
Starpharma Reports Positive VivaGel(R) Clinical Study Results MELBOURNE, Australia, May 12 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel)...
Starpharma Reports Positive VivaGel(R) Clinical Study Results Author : Starpharma Holdings Limited Category : Press Release News Alerts by Email click here ) News | Home MELBOURNE, Australia, May 12 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced positive results of...
Chronic fatigue syndrome clinical practice guidelines 2002 Associate Professor Graeme Stewart, PhD, FRACP, Immunologist, Westmead Hospital (Co-convenor); Royal Australasian College of Physicians; Former member, Ministerial CFS Review Committee.Members Dr James Bertouch, MD, FRACP, Rheumatologist,...
Novavax Reports First Quarter 2008 Financial Results ROCKVILLE, Md., May 9 PRNewswire-FirstCall Novavax, Inc.(Nasdaq: NVAX) today announced financial results for the first quarter 2008.
Novavax reported a net loss of $7.8 million ($0.13 loss per share) for the first quarter of 2008...
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced st Dr Josephine M Clayton (Chair) Head of Department of Palliative Care, Royal North Shore Hospital, Sydney, NSW; Senior Lecturer and Cancer Institute NSW Research Fellow, Faculty of Medicine, University of Sydney, Sydney, NSW.Dr Karen M...
Data Analysis Shows Promise in CABERNET Study NeoVista released updated results from a one-year feasibility study of the companys epiretinal brachytherapy for wet-form age-related macular degeneration at the 31st Annual Macula Society Meeting.The data from the study, which was...
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial CALGARY, May 9 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.('Oncolytics') announced today that it has begun patient enrolment in a clinical trial using intravenous administration of REOLYSIN(R) in combination with...
Repros Therapeutics Inc. Reports First Quarter 2008 Financial Results and Provides Clinical Development Progra Repros Therapeutics (NasdaqGM:RPRX) today announces financial results for the first quarter ended March 31, 2008 and provides a clinical development program overview.Financial Results Total revenues which consisted of only interest...
Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript Halozyme Therapeutics Inc.(HALO) Q1 2008 Earnings Call Executives David Ramsay - CFO Jonathan Lim - President and CEO Gregory Frost - VP and CSO Robert Little - VP and CCO Robert Uhl - Senior Director of Investor Relations Analysts...
Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript Halozyme Therapeutics Inc.(HALO) Q1 2008 Earnings Call Executives David Ramsay - CFO Jonathan Lim - President and CEO Gregory Frost - VP and CSO Robert Little - VP and CCO Robert Uhl - Senior Director of Investor Relations Analysts...
BioMimetic Therapeutics Reports 2008 First Quarter Results BioMimetic Therapeutics, Inc.(NASDAQ: BMTI) today reported its financial results as of and for the three months ended March 31, 2008.
For the three months ended March 31, 2008, the Company reported net income of $31.3 million, or $1.62...
Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results Inovio Biomedical Corporation (AMEX: INO) ('Inovio') today reported financial results for the quarter ended March 31, 2008.Total revenue for the quarter ended March 31, 2008, was $653,000, compared with $504,000 for the same period in...
Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results Inovio Biomedical Corporation (INO) (Inovio) today reported financial results for the quarter ended March 31, 2008.Total revenue for the quarter ended March 31, 2008, was $653,000, compared with $504,000 for the same period in 2007.
For...
Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX: INO - News) (Inovio) today reported financial results for the quarter ended March 31, 2008.Total revenue for the quarter ended March 31, 2008, was $653,000, compared with ...
PolyMedix receives clearance to initiate phase I clinical study of novel systemic antibiotic compound PolyMedix, Inc.has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ('CTA') for its defensin mimetic antibiotic compound, PMX-30063.This notice of no objection allows for the...
Medgenics Appoints VP of Clinical Affairs Medgenics, a US-incorporated biopharmaceutical company, announced that it has appointed Dr.Ehud Shoshani, former CEO of Quintiles, Israel, as its Vice President of Clinical Affairs.
Shoshani will manage the Company's Phase I/II ...
Medgenics Appoints VP of Clinical Affairs AM Medgenics, a US-incorporated biopharmaceutical company, announced that it has appointed Dr.Ehud Shoshani, former CEO of Quintiles, Israel, as its Vice President of Clinical Affairs.
Shoshani will manage the Company's Phase I/II...
ASCO And Cancer Foundation Recognize Community Oncology Practices' Dedication To Clinical Research The (ASCO) and The ASCO Cancer Foundation are honoring 10 community oncology practices for their efforts to improve care of people with cancer through participation in clinical trials. The Clinical Trials ...
Cardium Reports on First Quarter 2008 Highlights and Financial Results SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Cardium Therapeutics today reported recent highlights and developments, as well as financial results for its first quarter ended March 31, 2008.(Logo: www.newscom.com/cgi-bin/prnh/20051018...
Cardium Reports on First Quarter 2008 Highlights and Financial Results SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Cardium Therapeutics today reported recent highlights and developments, as well as financial results for its first quarter ended March 31, 2008.(Logo: http://www.newscom.com/cgi-bin/prnh/20051018...
Researchers launch lung cancer screening trial Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease.The trial*, funded by Cancer Research UK, aims to see if screening long-term smokers with chronic...
Cardium Reports on First Quarter 2008 Highlights and Financial Results SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Cardium Therapeutics today reported recent highlights and developments, as well as financial results for its first quarter ended March 31, 2008.(Logo: www.newscom.com/cgi-bin/prnh/20051018...
Cancer Care Specialists of Illinois receives national honor DECATUR - Cancer Care Specialists of Central Illinois announced Thursday that it was one of 10 community oncology practices nationwide to receive an American Society of Clinical Oncology honor for its involvement with clinical ...
